3X Genetics Inc.

Biotech Worcester, MA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Worcester, MA
Street
17 Briden St
Zip
01605

Offering

Total offering
$4M
Amount sold
$3.2M
First sale
Aug 5, 2024
Min investment
$10k
Securities
Equity, Debt
Federal exemption
Rule 506(b)
Investors so far
52

How this filing compares

Ranked #12 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 0.7× the median.

Other Massachusetts filings this week: Apnimed, Inc., BCV Emerge Fund V, L.P., LONG POINT INVESTORS, L.P., Neosoma, Inc., TA Realty Digital Real Estate Fund I, L.P.

Leadership

Kevin Donahue — Executive Officer (also: Director)

Filing details

3X Genetics Inc. filed a Form D with the SEC on March 25, 2026.

Other newest Biotech companies

Other newest companies in Massachusetts